Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value

被引:0
|
作者
V. B. Shivkumar
Manisha A. Atram
Nitin M. Gangane
机构
[1] Mahatma Gandhi Institute of Medical Sciences (MGIMS),Department of Pathology
[2] Mahatma Gandhi Institute of Medical Sciences,undefined
来源
关键词
Endometrial cancer; ER/PR expression; Her-2/neu status; p53; Ki67;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
相关论文
共 50 条
  • [21] HER-2/NEU, P53, AND DNA ANALYSES AS PROGNOSTICATORS FOR SURVIVAL IN ENDOMETRIAL CARCINOMA
    PISANI, AL
    BARBUTO, DA
    CHEN, D
    RAMOS, L
    LAGASSE, LD
    KARLAN, BY
    OBSTETRICS AND GYNECOLOGY, 1995, 85 (05): : 729 - 734
  • [22] Prognostic value of MUC4 and HER-2/neu expression in endometrial carcinoma
    Jimenez, F. A.
    Pearson, J. M.
    Ganjei, P.
    Hamilton-Nelson, K.
    Lucci, J. A.
    Carraway, K.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S83 - S84
  • [23] EXPRESSION OF ER, PR, P53, AND KI67 IN NONPROLIFERATIVE, HYPERPLASTIC AND MALIGNANT APOCRINE LESIONS OF THE BREAST
    TAVASSOLI, FA
    MAN, YG
    LABORATORY INVESTIGATION, 1995, 72 (01) : A26 - A26
  • [24] Coexistence of her2, ki67, and p53 in osteosarcoma: A strong prognostic factor
    Mardanpour, Keykhosro
    Rahbar, Mahtab
    Mardanpour, Sourena
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2016, 8 (05) : 210 - 214
  • [25] Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications
    Caigang Liu
    Hao Zhang
    Chen Shuang
    Yang Lu
    Feng Jin
    Huimian Xu
    Ping Lu
    Medical Oncology, 2010, 27 : 747 - 752
  • [26] Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications
    Liu, Caigang
    Zhang, Hao
    Shuang, Chen
    Lu, Yang
    Jin, Feng
    Xu, Huimian
    Lu, Ping
    MEDICAL ONCOLOGY, 2010, 27 (03) : 747 - 752
  • [27] The prognostic significance of p53, p27kip1, p21waf1, HER-2/neu, and ki67 proteins expression in gastric cancer:: A clinicopathological and lmmunohistochemical study of 121 Arab patients
    Al-Moundhri, MS
    Nirmala, V
    Al-Hadabi, I
    Al-Mawaly, K
    Burney, I
    Al-Nabhani, M
    Thomas, V
    Ganguly, SS
    Grant, C
    JOURNAL OF SURGICAL ONCOLOGY, 2005, 91 (04) : 243 - 252
  • [28] Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
    Jongen, Vincent H. W. M.
    Briet, Justine M.
    de Jong, Renske A.
    Joppe, Erna
    ten Hoor, Klaske A.
    Boezen, H. M.
    Evans, Dean B.
    Hollema, Harry
    van der Zee, Ate G. J.
    Nijman, Hans W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (04) : 670 - 676
  • [29] Male breast carcinoma: Correlation of ER, PR, Ki-67, Her2-neu, and p53 with treatment and survival, a study of 65 cases
    Wang-Rodriguez, J
    Cross, K
    Gallagher, S
    Djahanban, M
    Armstrong, JM
    Wiedner, N
    Shapiro, DH
    MODERN PATHOLOGY, 2002, 15 (08) : 853 - 861
  • [30] Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and Prognostic Significance in Hepatocellular Carcinoma
    Stroescu, Cezar
    Dragnea, Adrian
    Ivanov, Bogdan
    Pechianu, Catalin
    Herlea, Vlad
    Sgarbura, Olivia
    Popescu, Andra
    Popescu, Irinel
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2008, 17 (04) : 411 - 417